CIK 0001806952
- Non-accelerated filer
- Smaller reporting company
Lyell Immunopharma, Inc.
Sign in to watch- Ticker
- LYEL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 833006753
- Phone
- +1 650-695-0677
- Business address
- 201 HASKINS WAY, SOUTH SAN FRANCISCO, CA, 94080
- 4 Open-market buy Director bought 35,640 shares at $0.56 ($19,958)
- 4 Open-market buy Director bought 200,000 shares at $0.58 ($115,220)
- 4 Open-market buy Director bought 158,000 shares at $0.60 ($94,942)
- 4 Open-market buy Chief Financial Officer bought 200,000 shares at $0.56 ($111,620)
- 4 Open-market buy President and CEO bought 175,000 shares at $0.61 ($106,190)
- 4 Grant or award Chief Business Officer acquired 112,500 shares (grant or award)
- 4 Grant or award President and CEO acquired 337,500 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 112,500 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 112,500 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 112,500 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Business Officer acquired 50,000 shares (grant or award)
Page 5 of 9 · 173 filings